Research and Innovation in Oncology and Immunology for Novel Biological Therapies in Solid Tumors

Our research and innovation teams were formed as a biological protein engineering unit and launched in the Johnson & Johnson Innovation Hub/JLABS Incubator in 2019.
Our mission/concept is to identify breakthrough and disruptive technologies via partnering with research institutions, and then by leveraging our expertise in proven next-generation biological formats, to design and build first-in-class biological protein-engineered therapies for solid tumors with unmet need.

Biological Platforms & Manufacturing Technologies